The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.
Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.
A new combination of acetaminophen and ibuprofen will soon hit the market.
Tzield (teplizumab-mzwv) injections can delay onset by several months or years.
As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.
A new migraine medication, various generics, and more.